These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7923878)

  • 1. Plasma half-lives and bioavailability of human monoclonal Rh D antibodies BRAD-3 and BRAD-5 following intramuscular injection into Rh D-negative volunteers.
    Goodrick J; Kumpel B; Pamphilon D; Fraser I; Chapman G; Dawes B; Anstee D
    Clin Exp Immunol; 1994 Oct; 98(1):17-20. PubMed ID: 7923878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Rh D monoclonal antibodies (BRAD-3 and BRAD-5) cause accelerated clearance of Rh D+ red blood cells and suppression of Rh D immunization in Rh D- volunteers.
    Kumpel BM; Goodrick MJ; Pamphilon DH; Fraser ID; Poole GD; Morse C; Standen GR; Chapman GE; Thomas DP; Anstee DJ
    Blood; 1995 Sep; 86(5):1701-9. PubMed ID: 7655002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo studies of monoclonal anti-D and the mechanism of immune suppression.
    Kumpel BM
    Transfus Clin Biol; 2002 Jan; 9(1):9-14. PubMed ID: 11889904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal anti-D development programme.
    Kumpel BM
    Transpl Immunol; 2002 Aug; 10(2-3):199-204. PubMed ID: 12216950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal anti-D for prophylaxis of RhD haemolytic disease of the newborn.
    Kumpel BM
    Transfus Clin Biol; 1997 Jul; 4(4):351-6. PubMed ID: 9269715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of IgG anti-D bound to D-positive red cells infused into D-negative subjects after intramuscular injection of monoclonal anti-D.
    Kumpel BM; Judson PA
    Transfus Med; 1995 Jun; 5(2):105-12. PubMed ID: 7655572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro functional activity of IgG1 and IgG3 polyclonal and monoclonal anti-D.
    Kumpel BM
    Vox Sang; 1997; 72(1):45-51. PubMed ID: 9031501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.
    Kumpel BM; Rademacher TW; Rook GA; Williams PJ; Wilson IB
    Hum Antibodies Hybridomas; 1994; 5(3-4):143-51. PubMed ID: 7756579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine monoclonal antibodies reactive with a human monoclonal anti-RhD antibody (BRAD-5).
    Walker RY; Andrew S; Kumpel BM; Austin EB
    Transfus Med; 2000 Sep; 10(3):225-31. PubMed ID: 10972918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and safety of recombinant anti-RhD in healthy RhD-negative male volunteers.
    Bichler J; Spycher MO; Amstutz HP; Andresen I; Gaede K; Miescher S
    Transfus Med; 2004 Apr; 14(2):165-71. PubMed ID: 15113381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-Rho[D] antigen monoclonal antibodies. II. Serological characteristics of monoclonal IgG1 antibodies].
    Olovnikova NI; Belkina EV; Lemeneva LN; Berkovskiĭ AL; Deriugina EI; Chertkov IL
    Gematol Transfuziol; 1992; 37(9-10):5-9. PubMed ID: 1490578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a directly conjugated monoclonal anti-D (BRAD-3) for quantification of fetomaternal hemorrhage by flow cytometry.
    Lloyd-Evans P; Kumpel BM; Bromelow I; Austin E; Taylor E
    Transfusion; 1996 May; 36(5):432-7. PubMed ID: 8693508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcytosis of IgG anti-D by human term trophoblast cells in culture.
    Kumpel BM; Sooranna SR
    Transfus Med; 1996 Jun; 6(2):115-20. PubMed ID: 8809958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of Rh D antigen sites on weak D and D variant red cells by flow cytometry.
    Jones JW; Lloyd-Evans P; Kumpel BM
    Vox Sang; 1996; 71(3):176-83. PubMed ID: 8912461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes.
    Wiener E; Jolliffe VM; Scott HC; Kumpel BM; Thompson KM; Melamed MD; Hughes-Jones NC
    Immunology; 1988 Oct; 65(2):159-63. PubMed ID: 3192267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in-vitro assessment of the functional activity of monoclonal anti-D.
    Hadley AG; Kumpel BM; Leader K; Merry AH; Brojer E; Zupanska B
    Clin Lab Haematol; 1989; 11(1):47-54. PubMed ID: 2495881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of IgG1 monoclonal anti-Rh(D): an investigation using ADCC and macrophage binding assays.
    Armstrong SS; Wiener E; Garner SF; Urbaniak SJ; Contreras M
    Br J Haematol; 1987 Jun; 66(2):257-62. PubMed ID: 3038161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Turnover rate of anti-D IgG injected during pregnancy.
    Eklund J; Hermann M; Kjellman H; Pohja P
    Br Med J (Clin Res Ed); 1982 Mar; 284(6319):854-5. PubMed ID: 6802325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human monoclonal anti-D-induced clearance of human D-positive red cells in a chimpanzee model.
    Blancher A; Socha WW; Roubinet F; Rowe AW; Broly H; Byrne P; Holuigue M; Bouzidi A; Huart JJ; Ruffié J
    Vox Sang; 1993; 65(1):47-54. PubMed ID: 8362514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced opsonisation of Rhesus D-positive human red blood cells by recombinant polymeric immunoglobulin G anti-G antibodies.
    Díaz-Solano D; Fuenmayor J; Montaño RF
    Blood Transfus; 2018 Feb; 16(2):200-208. PubMed ID: 28686149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.